DYN logo

Dyne Therapeutics (DYN)

Profile

Full Name

Dyne Therapeutics, Inc.

Ticker Symbol

DYN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 17, 2020

Indexes

Not included

Website

http://www.dyne-tx.com

Employees

191

Key Details

Price

$7.25(+3.05%)

Market cap

$820.70M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.37(+14.68% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.25
DYN price is $7.25

30-Day Relative Volume

1.07
DYN 30-day relative volume is 1.07

Price Performance

Price Today change

+3.05%
DYN price is up +3.05% today

Price YTD change

-69.21%
DYN price is down -69.21% since January 1st

Price 1-year change

-71.93%
DYN price is down -71.93% year-on-year

Price 3-year change

-24.27%
DYN price is down -24.27% over the past 3 years

Price Range

Price All-time high

$47.45
DYN price is currently -84.71% below its historical high of $47.45

Price 3-year low

$4.30
DYN price is currently +68.72% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$820.70M
DYN market capitalization is $820.70 million

Market cap 3-year change

+65.81%
DYN market capitalization is up +65.81% over the past 3 years

Market cap All-time high

$4.74B
DYN market capitalization is currently -82.69% below its historical high of $4.74 billion

Market cap sector rank

74.86%
DYN market capitalization is higher than 74.86% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+29.89%
DYN shares outstanding is up +29.89% year-on-year

Shares Outstanding 3-Year Change

+118.94%
DYN shares outstanding is up +118.94% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.62
DYN beta is 1.62

200-day SMA

$27.38
DYN price is currently -73.50% below its 200-day simple moving average

50-day SMA

$12.16
DYN price is currently -40.32% below its 50-day simple moving average

RSI

27.58
DYN 14-day relative strength index is 27.58

Volume

1.07
DYN 30-day relative volume is 1.07

ATR

$0.87
DYN average true range is $0.87

10-day Historical Volatility

128.47%
DYN 10-day historical volatility is 128.47%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
DYN annual revenue value is unknown

Revenue Analysts estimate

-
DYN annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
DYN annual revenue 1-year change is unknown

Revenue Sector rank

-
DYN annual revenue is unknown

EPS

EPS

-$3.37
DYN annual earnings per share is -$3.37

EPS Analysts estimate

-$3.48
DYN annual earnings per share is currently -3.26% lower than the consensus analysts' forecast

EPS 1-year change

+14.68%
DYN annual earnings per share is up +14.68% year-on-year

EPS Sector rank

26.18%
DYN annual earnings per share is higher than 26.18% of companies in Healthcare sector

Profit

Gross profit

-
DYN annual gross profit value is unknown

Gross margin

-
DYN annual gross profit margin value is unknown

Operating profit

-$343.89M
DYN annual operating income is -$343.89 million

Operating margin

-
DYN annual operating profit margin value is unknown

Net income

-$317.42M
DYN annual net profit is -$317.42 million

Net margin

-
DYN annual net profit margin value is unknown

Expenses

Total expenses

$343.89M
DYN annual total expenses is $343.89 million

Operating expenses

$343.89M
DYN annual total operating expenses is $343.89 million

Cost of goods sold

-
DYN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$62.48M
DYN annual SGA is $62.48 million

Depreciation and amortization

$1.67M
DYN annual depreciation & amortization is $1.67 million

Interest expense

-
DYN annual interest expense value is unknown

Income tax

-
DYN annual income tax value is unknown

EBIT & EBITDA

EBIT

-$343.89M
DYN annual earnings before interest & taxes is -$343.89 million

EBITDA

-$342.21M
DYN annual EBITDA is -$342.21 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$691.23M
DYN annual total assets is $691.23 million

Non current assets

$31.95M
DYN annual long term assets is $31.95 million

Current assets

$659.28M
DYN annual total current assets is $659.28 million

Cash and cash equivalents

$435.45M
DYN annual cash & cash equivalents is $435.45 million

Accounts receivable

-
DYN annual accounts receivable value is unknown

Inventory

-
DYN annual inventory value is unknown

Liabilities

Total liabilities

$61.40M
DYN annual total liabilities is $61.40 million

Long term liabilities

$19.14M
DYN annual total long term liabilities is $19.14 million

Current liabilities

$42.26M
DYN annual total current liabilities is $42.26 million

Accounts payable

$6.56M
DYN annual accounts payable is $6.56 million

Debt

Total debt

$23.99M
DYN annual total debt is $23.99 million

Total debt 1-year change

-12.5%
DYN annual total debt is down -12.5% year-on-year

Long term debt

$19.14M
DYN annual long term debt is $19.14 million

Short term debt

$4.85M
DYN annual short term debt is $4.85 million

Equity & Capital

Shareholders equity

$629.84M
DYN annual stockholders equity is $629.84 million

Book value

$629.84M
DYN annual book value is $629.84 million

Retained earnings

-$949.93M
DYN annual retained earnings is -$949.93 million

Working capital

$617.02M
DYN annual working capital is $617.02 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$292.37M
DYN annual cash flow from operations is -$292.37 million

Cash from operations 1-year change

-55.38%
DYN annual cash flow from operations is down -55.38% year-on-year

Cash from investing

-$204.08M
DYN annual cash flow from investing activities is -$204.08 million

Cash from investing 1-year change

-344.96%
DYN annual cash flow from investing activities is down -344.96% year-on-year

Cash from financing

$809.89M
DYN annual cash flow from financing activities is $809.89 million

Cash from financing 1-year change

+1390.92%
DYN annual cash flow from financing activities is up +1390.92% year-on-year

CAPEX

CAPEX

-
DYN annual capital expenditures value is unknown

CAPEX 1-year change

-
DYN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$294.75M
DYN annual free cash flow is -$294.75 million

Free cash flow 1-year change

-56.04%
DYN annual free cash flow is down -56.04% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
DYN annual gross profit margin value is unknown

Operating margin

-
DYN annual operating profit margin value is unknown

Net margin

-
DYN annual net profit margin value is unknown

ROA & ROE

ROA

-45.92%
DYN annual return on assets is -45.92%

ROE

-50.40%
DYN annual return on equity is -50.40%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DYN price to earnings ratio value is unknown

PE ratio Sector rank

-
DYN price to earnings ratio is unknown

PB Ratio

PB ratio

1.30
DYN price to book ratio is 1.30

PB ratio Sector rank

51.07%
DYN price to book ratio is higher than 51.07% of companies in Healthcare sector

PS Ratio

PS ratio

-
DYN price to sales ratio value is unknown

PS ratio Sector rank

-
DYN price to sales ratio is unknown

Enterprise value

Enterprise value

$409.23M
DYN enterprise value is $409.23 million

Enterprise value Sector rank

67.22%
DYN enterprise value is higher than 67.22% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.20
DYN EV/EBITDA is -1.20

EV/EBITDA Sector rank

39.88%
DYN EV/EBITDA is higher than 39.88% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

15.60
DYN annual current ratio is 15.60

Quick ratio

-
DYN annual quick ratio value is unknown

Leverage

Debt to equity

0.04
DYN annual debt to equity ratio is 0.04

Interest coverage ratio

-
DYN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
DYN piotroski f-score value is unknown

Altman Z-Score

-
DYN altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 21, 25 JP Morgan
Neutral
Mar 17, 25 HC Wainwright & Co.
Buy
Mar 17, 25 Chardan Capital
Buy
Mar 12, 25 BMO Capital
Outperform
Mar 7, 25 Scotiabank
Sector Outperform
Feb 28, 25 Piper Sandler
Overweight
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 28, 25 Chardan Capital
Buy
Jan 24, 25 Guggenheim
Buy
Jan 14, 25 RBC Capital
Outperform

Institutional Ownership

Similar stocks

CMRX logo
Chimerix (CMRX)
OCS logo
Oculis Holding AG (OCS)
GRAL logo
GRAIL (GRAL)
ETNB logo
89bio (ETNB)
ELVN logo
Enliven Therapeutics (ELVN)
NTLA logo
Intellia Therapeutics (NTLA)
COLL logo
Collegium Pharmaceutical (COLL)
STAA logo
STAAR Surgical (STAA)
VIR logo
Vir Biotechnology (VIR)
  • What is the ticker symbol for Dyne Therapeutics?
  • Does Dyne Therapeutics pay dividends?
  • What sector is Dyne Therapeutics in?
  • What industry is Dyne Therapeutics in?
  • What country is Dyne Therapeutics based in?
  • When did Dyne Therapeutics go public?
  • Is Dyne Therapeutics in the S&P 500?
  • Is Dyne Therapeutics in the NASDAQ 100?
  • Is Dyne Therapeutics in the Dow Jones?
  • When was Dyne Therapeutics's last earnings report?
  • When does Dyne Therapeutics report earnings?
  • Should I buy Dyne Therapeutics stock now?

What is the ticker symbol for Dyne Therapeutics?

The ticker symbol for Dyne Therapeutics is NASDAQ:DYN

Does Dyne Therapeutics pay dividends?

No, Dyne Therapeutics does not pay dividends

What sector is Dyne Therapeutics in?

Dyne Therapeutics is in the Healthcare sector

What industry is Dyne Therapeutics in?

Dyne Therapeutics is in the Biotechnology industry

What country is Dyne Therapeutics based in?

Dyne Therapeutics is headquartered in United States

When did Dyne Therapeutics go public?

Dyne Therapeutics's initial public offering (IPO) was on September 17, 2020

Is Dyne Therapeutics in the S&P 500?

No, Dyne Therapeutics is not included in the S&P 500 index

Is Dyne Therapeutics in the NASDAQ 100?

No, Dyne Therapeutics is not included in the NASDAQ 100 index

Is Dyne Therapeutics in the Dow Jones?

No, Dyne Therapeutics is not included in the Dow Jones index

When was Dyne Therapeutics's last earnings report?

Dyne Therapeutics's most recent earnings report was on Feb 27, 2025

When does Dyne Therapeutics report earnings?

The next expected earnings date for Dyne Therapeutics is May 2, 2025

Should I buy Dyne Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page